RNVA (RNVA) Stock Price & Analysis
RNVA (RNVA) rose 0.00% to USD 0 as of June 10, 2026 at 05:01 UTC, according to Nexqual real-time market data.
RNVA last closed at USD 0; the session ranged USD 0–0 on volume of 497,849 shares. Market capitalization is $4.31M, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:01 UTC.
Key Statistics (as of June 10, 2026 at 05:01 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 497,849 shares |
| Market Cap | $4.31M |
| Exchange | PNK |
Technical Analysis (RNVA)
Nexqual's technical model rates RNVA "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:01 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (RNVA)
Wall Street analysts rate RNVA "None", per Nexqual as of June 10, 2026 at 05:01 UTC.
| Consensus Rating | None |
|---|
Earnings (RNVA)
Source: Nexqual, June 10, 2026 at 05:01 UTC.
Financials & Fundamentals (RNVA)
| Total Revenue | $18.69M |
|---|---|
| Revenue Growth (YoY) | +25.20% |
| Gross Margin | +59.46% |
| Operating Margin | -16.99% |
| Profit Margin | -41.36% |
| Current Ratio | 0.16 |
| Total Cash | $123,898 |
| Total Debt | $12.24M |
| Free Cash Flow | $3.44M |
Source: Nexqual, June 10, 2026 at 05:01 UTC.
Financial Health Score (RNVA)
Nexqual rates RNVA's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:01 UTC.
| Growth | Strong — Revenue +25% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $124K cash vs $12M debt |
| Cash Flow | Strong — FCF $3M, 18% margin |
| Efficiency | Mixed — No data |
Ownership (RNVA)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +9.99% |
| Shares Outstanding | 43.05B |
| Short % of Float | +8.21% |
Source: Nexqual, June 10, 2026 at 05:01 UTC.
Leadership (RNVA)
RNVA is led by Seamus Lagan (age 56), President, CEO, Interim CFO & Director, per Nexqual as of June 10, 2026 at 05:01 UTC.
| President, CEO, Interim CFO & Director | Seamus Lagan (age 56) |
|---|---|
| Director of Human Resources | Karen Taylor |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IDXG | Interpace Biosciences, Inc. | USD 1.74 | ▲ 4.19% |
| UBQU | Ubiquitech Software Corp. | USD 0 | ▲ 0% |
| ECEZ | Ecosciences, Inc. | USD 0 | ▲ 0% |
| FTEG | FOR THE EARTH CORPORATION | USD 0 | ▲ 0% |
| PULM | Pulmatrix, Inc. | USD 1.38 | ▲ 3.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:01 UTC. This page is informational and not investment advice.